Share：
Share this content in WeChat
X
[Chinese][PDF]4554
• Special Focus •
Clinical value of CMR left ventricular long-axis strain in predicting LGE in cardiac amyloidosis secondary to multiple myeloma
HU Mengyao  SONG Yipei  ZHENG Tian  YU Sisi  LI Shuhao  TAO Xinwei  GONG Lianggeng 

Cite this article as: Hu MY, Song YP, Zheng T, et al. Clinical value of CMR left ventricular long-axis strain in predicting LGE in cardiac amyloidosis secondary to multiple myeloma[J]. Chin J Magn Reson Imaging, 2022, 13(12): 26-31, 44. DOI:10.12015/issn.1674-8034.2022.12.005.


[Abstract] Objective To investigate the predictive value of left ventricular long-axis strain (LV LAS) with cardiac magnetic resonance (CMR) in patients with cardiac amyloidosis secondary to multiple myeloma (MM) with late gadolinium enhancement (LGE).Materials and Methods The clinical data and CMR parameters of 33 patients with CA secondary to MM and 29 control groups were retrospectively analyzed. CA patients secondary to MM were divided into LGE (+) group and LGE (-) group according to the presence or absence of abnormal enhancement, univariate logistic regression and receiver operating characteristic (ROC) curve was used to analyze the predictive value of CMR parameters for LGE in CA patients secondary to MM. The intra-class correlation coefficient (ICC) test was used to analyze the differences between and within observers of the left ventricular long axis strain (LV LAS) of CMR.Results Most patients with CA secondary to MM are elderly men (accounting for 72.7%), with complex clinical symptoms and abnormal results such as electrocardiograms. Compared with the LGE (-) group, patients with LGE (+) had lower left ventricular ejection fraction (LVEF), cardiac index (CI), greater left ventricular mass index (LVMI), and more severe LV LAS damage (P＜0.05). Univariate logistic regression analysis showed that there were statistically significant differences in the prediction of LGE positivity by LVEF, CI, LVMI and LV LAS (P＜0.05). ROC analysis showed that LV LAS＜-14.3% [area under the curve (AUC): 0.909, sensitivity: 90.5%, specificity: 75.0%, 95% CI: 0.756-0.981] and LVMI＞83.9 g/m² (AUC: 0.877, sensitivity: 71.4%, specificity: 100.0%, 95% CI: 0.716-0.965) predicted good LGE positive efficacy in CA patients.Conclusions LV LAS can not only quantitatively assess the severity impaired of left ventricular function in CA patients secondary to MM, but also has predictive value for LGE. It can provide decision-making for early clinical quantitative assessment of cardiac involvement and prevention of serious adverse events in patients with renal insufficiency.
[Keywords] multiple myeloma；cardiac amyloidosis；left ventricle；long-axis strain；cardiac magnetic resonance；magnetic resonance imaging；late gadolinium enhancement

HU Mengyao1   SONG Yipei1   ZHENG Tian1   YU Sisi1   LI Shuhao1   TAO Xinwei2   GONG Lianggeng1*  

1 Medical Imaging Center, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China

2 Department of Imaging Diagnosis, Bayer HealthCare, Beijing 100176, China

Gong LG, E-mail: gong111999@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS National Natural Science Foundation of China (No. 81860316); Natural Science Foundation of Jiangxi Province (No. 20212ACB206021).
Received  2022-08-08
Accepted  2022-11-29
DOI: 10.12015/issn.1674-8034.2022.12.005
Cite this article as: Hu MY, Song YP, Zheng T, et al. Clinical value of CMR left ventricular long-axis strain in predicting LGE in cardiac amyloidosis secondary to multiple myeloma[J]. Chin J Magn Reson Imaging, 2022, 13(12): 26-31, 44. DOI:10.12015/issn.1674-8034.2022.12.005.

[1]
Singh G, Savage NM, Jillella AP, et al. Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival[J]. Lab Med, 2022, 53(2): 145-148. DOI: 10.1093/labmed/lmab054.
[2]
Ihne S, Morbach C, Sommer C, et al. Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed Disease[J]. Dtsch Arztebl Int, 2020, 117(10): 159-166. DOI: 10.3238/arztebl.2020.0159.
[3]
Siddiqi OK, Ruberg FL. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment[J]. Trends Cardiovasc Med, 2018, 28(1): 10-21. DOI: 10.1016/j.tcm.2017.07.004.
[4]
Cariou E, Bennani Smires Y, Victor G, et al. Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrop hy and impact on prognosis[J]. Amyloid, 2017, 24(2): 101-109. DOI: 10.1080/13506129.2017.1333956.
[5]
Bhatti S, Watts E, Syed F, et al. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(9): 970-977. DOI: 10.1093/ehjci/jew101.
[6]
Wan K, Sun J, Yang D, et al. Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis[J]. Radiology, 2018, 288(1): 73-80. DOI: 10.1148/radiol.2018172435.
[7]
Li X, Li J, Lin L, et al. Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis[J]. Cardiovasc Diagn Ther, 2020, 10(3): 470-480. DOI: 10.21037/cdt-20-181.
[8]
Huang S, Xu HY, Diao KY, et al. Left ventricular global function index by magnetic resonance imaging-a novel marker for differentiating cardiac amyloidosis from hypertrophic cardiomyopathy[J]. Sci Rep, 2020, 10(1): 4707-4714. DOI: 10.1038/s41598-020-61608-9.
[9]
Hematologists Branch of Chinese Medical Doctor Association, Hematology Branch of Chinese Medical Association, Multiple Myeloma Professional Committee of Chinese Medical Doctor Association. The guidelines for the diagnosis and management of multiple myeloma in China (2020 revision)[J]. Chin J Intern Med, 2020, 59(5): 341-346. DOI: 10.3760/cma.j.cn112138-20200304-00179.
[10]
Bhatti S, Vallurupalli S, Ambach S, et al. Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study[J]. Int J Cardiovas Imag, 2018, 34(1): 27-33. DOI: 10.1007/s10554-016-0998-6.
[11]
Wu Y, Pu C, Zhu W, et al. A Risk Score to Diagnose Cardiac Involvement and Provide Prognosis Information in Patients at Risk of Cardiac Light-Chain Amyloidosis[J/OL]. Front Cardiovasc Med, 2022, 9: 817456 [2022-07-30]. https://www.frontiersin.org/articles/10.3389/fcvm.2022.817456/full. DOI: 10.3389/fcvm.2022.817456.
[12]
Hematologists Branch of Chinese Medical Doctor Association, Hematology Branch of Chinese Medical Association. Guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)[J]. Chin J Intern Med, 2022, 61(5): 480-487. DOI: 10.3760/cma.j.cn112138-20220309-00165.
[13]
Giusca S, Steen H, Montenbruck M, et al. Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance[J]. J Cardiovasc Magn Reson, 2021, 23(1): 92-104. DOI: 10.1186/s12968-021-00775-8.
[14]
Uzan C, Lairez O, Raud-Raynier P, et al. Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis[J]. Amyloid, 2018, 25(1): 18-25. DOI: 10.1080/13506129.2017.1417121.
[15]
Tan Z, Yang Y, Wu X, et al. Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study[J]. Int J Cardiovasc Imaging, 2022, 38: 1519-1532. DOI: 10.1007/s10554-022-02534-x.
[16]
Ochs MM, Fritz T, Arenja N, et al. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis[J]. J Cardiovasc Magn Reson, 2017, 19(1): 87-95. DOI: 10.1186/s12968-017-0402-2.
[17]
Bodez D, Ternacle J, Guellich A, et al. Prognostic value of right ventricular systolic function in cardiac amyloidosis[J]. Amyloid, 2016, 23(3): 158-167. DOI: 10.1080/13506129.2016.1194264.
[18]
Wan K, Lin J, Guo X, et al. Prognostic Value of Right Ventricular Dysfunction in Patients With AL Amyloidosis: Comparison of Different Techniques by Cardiac Magnetic Resonance[J]. J Magn Reson Imaging, 2020, 52(5): 1441-1448. DOI: 10.1002/jmri.27200.
[19]
Kuetting DL, Homsi R, Sprinkart AM, et al. Quantitative assessment of systolic and diastolic function in patients with LGE negative systemic amyloidosis using CMR[J]. Int J Cardiol, 2017, 232: 336-341. DOI: 10.1016/j.ijcard.2016.12.054.
[20]
Knight DS, Zumbo G, Barcella W, et al. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles[J]. JACC Cardiovasc Imaging, 2019, 12(5): 823-833. DOI: 10.1016/j.jcmg.2018.02.016.
[21]
Illman JE, Arunachalam SP, Arani A, et al. MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis[J]. Amyloid, 2018, 25(2): 101-108. DOI: 10.1080/13506129.2018.1465406.
[22]
Liu H, Fu H, Guo YK, et al. The prognostic value of right ventricular deformation derived from cardiac magnetic resonance tissue tracking for all-cause mortality in light-chain amyloidosis patients[J]. Cardiovasc Diagn Ther, 2020, 10(2): 161-172. DOI: 10.21037/cdt.2020.01.03.
[23]
Romano S, Judd RM, Kim RJ, et al. Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study[J]. JACC Cardiovasc Imaging, 2019, 12(9): 1769-1779. DOI: 10.1016/j.jcmg.2018.10.003.
[24]
Arenja N, Andre F, Riffel JH, et al. Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis[J]. J Cardiovasc Magn Reson, 2019, 21(1): 53-64. DOI: 10.1186/s12968-019-0564-1.
[25]
Kado Y, Obokata M, Nagata Y, et al. Cumulative Burden of Myocardial Dysfunction in Cardiac Amyloidosis Assessed Using Four-Chamber Cardiac Strain[J]. J Am Soc Echocardiogr, 2016, 29(11): 1092-1099. e2. DOI: 10.1016/j.echo.2016.07.017.
[26]
Liu Z, Zhang L, Liu M, et al. Myocardial Injury in Multiple Myeloma Patients With Preserved Left Ventricular Ejection Fraction: Noninvasive Left Ventricular Pressure-Strain Myocardial Work[J/OL]. Front Cardiovasc Med, 2021, 8: 782580 [2022-07-30]. https://www.frontiersin.org/articles/10.3389/fcvm.2021.782580/full. DOI: 10.3389/fcvm.2021.782580.
[27]
Schuster A, Backhaus SJ, Stiermaier T, et al. Fast manual long-axis strain assessment provides optimized cardiovascular event prediction following myocardial infarction[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(11): 1262-1270. DOI: 10.1093/ehjci/jez077.
[28]
Raina S, Lensing SY, Nairooz RS, et al. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis[J]. JACC Cardiovasc Imaging, 2016, 9(11): 1267-1277. DOI: 10.1016/j.jcmg.2016.01.036.
[29]
Shang Z, Zhao ML, Wang XY, et al. Multidisciplinary team management and long-term prognosis of an elderly patient with severe cardiac amyloidosis complicated with multiple myeloma[J]. J Geriatr Cardiol, 2022, 19(5): 398-402. DOI: 10.11909/j.issn.1671-5411.2022.05.006.
[30]
Chen J, Liu H, Li L, et al. Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function[J/OL]. J Clin Lab Anal, 2019, 33(5): e22888 [2022-07-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595344/. DOI: 10.1002/jcla.22888.
[31]
Leng S, Tan RS, Zhao X, et al. Fast long-axis strain: a simple, automatic approach for assessing left ventricular longitudinal function with cine cardiovascular magnetic resonance[J]. Eur Radiol, 2020, 30(7): 3672-3683. DOI: 10.1007/s00330-020-06744-6.

PREV The relationship of left ventricular myocardial fibrosis and left atrial function parameters of patients with hypertensive heart disease
NEXT Differential diagnostic value of T1 mapping and tissue tracking techniques in diseases associated with left ventricular hypertrophy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn